Todd E. Rasmussen

Todd E. Rasmussen

Auto-generated profile, based on publicly available information

Todd E. Rasmussen

Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in The Lancet Neurology
Verified
Journal Article
Closed access
AMAndrew I R Maas
Andrew I R Maas
DMDavid K Menon
David K Menon
PAP David Adelson
P David Adelson
NANada Andelic
Nada Andelic
MBMichael J Bell
Michael J Bell
FZFabrizio Zumbo
Fabrizio Zumbo

1 December 2012 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Closed access
BEBrian J. Eastridge
Brian J. Eastridge
RMRobert L. Mabry
Robert L. Mabry
PSPeter Seguin
Peter Seguin
JCJoyce Cantrell
Joyce Cantrell
TTTerrill Tops
Terrill Tops
LBLorne H. Blackbourne
Lorne H. Blackbourne
Critical evaluation of all aspects of combat casualty care, including mortality, with a special focus on the incidence and causes of potentially preventable deaths among US combat fatalities, is central to identifying gaps in knowledge, training, equipment, and execution of battlefield trauma care. The impetus to produce this analysis was to develop a comprehensive perspective of battlefield death, concentrating on deaths that occurred in the pre-medical treatment facility (pre-MTF) environment. The Armed Forces Medical Examiner Service Mortality Surveillance Division was used to identify Operation Iraqi Freedom and Operation Enduring Freedom combat casualties from October 2001 to June 2011 who died from injury in the deployed environment. The autopsy records, perimortem records, photographs on file, and Mortality Trauma Registry of the Armed Forces Medical Examiner Service were used to compile mechanism of injury, cause of injury, medical intervention performed, Abbreviated Injury Scale (AIS) score, and Injury Severity Score (ISS) on all lethal injuries. All data were used by the expert panel for the conduct of the potential for injury survivability assessment of this study. For the study interval between October 2001 and June 2011, 4,596 battlefield fatalities were reviewed and analyzed. The stratification of mortality demonstrated that 87.3% of all injury mortality occurred in the pre-MTF environment. Of the pre-MTF deaths, 75.7% (n = 3,040) were classified as nonsurvivable, and 24.3% (n = 976) were deemed potentially survivable (PS). The injury/physiologic focus of PS acute mortality was largely associated with hemorrhage (90.9%). The site of lethal hemorrhage was truncal (67.3%), followed by junctional (19.2%) and peripheral-extremity (13.5%) hemorrhage. Most battlefield casualties died of their injuries before ever reaching a surgeon. As most pre-MTF deaths are nonsurvivable, mitigation strategies to impact outcomes in this population need to be directed toward injury prevention. To significantly impact the outcome of combat casualties with PS injury, strategies must be developed to mitigate hemorrhage and optimize airway management or reduce the time interval between the battlefield point of injury and surgical intervention.Understanding battlefield mortality is a vital component of the military trauma system. Emphasis on this analysis should be placed on trauma system optimization, evidence-based improvements in Tactical Combat Casualty Care guidelines, data-driven research, and development to remediate gaps in care and relevant training and equipment enhancements that will increase the survivability of the fighting force.

1 February 2012 in Archives of Surgery
Verified
Journal Article
Open access
PDF file
JMJonathan Morrison
Jonathan Morrison
TRTodd E. Rasmussen
Todd E. Rasmussen
MMMark J. Midwinter
Mark J. Midwinter
Vascular disruption with concomitant hemorrhage is a leading cause of death in civilian and military trauma.1,2 Experience from the wars in Iraq and Afghanistan has led to advances in resuscitation for hemorrhagic shock, with identification of optimum ratios of blood components to be used in this setting.3-5 These new strategies are based on early and balanced administration of packed red blood cells (PRBCs), fresh frozen plasma (FFP), platelets, and cryoprecipitate to restore circulating volume and clotting factors.6 Despite these advances, the effectiveness of a medication to improve mortality in the setting of hemorrhagic shock has not been established.

1 September 2013 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Closed access
MBMegan L. Brenner
Megan L. Brenner
LMLaura J. Moore
Laura J. Moore
JDJoseph J. DuBose
Joseph J. DuBose
GTGeorge H. Tyson
George H. Tyson
MMMichelle K. McNutt
Michelle K. McNutt
TRTodd E. Rasmussen
Todd E. Rasmussen
A requirement for improved methods of hemorrhage control and resuscitation along with the translation of endovascular specialty skills has resulted in reappraisal of resuscitative endovascular balloon occlusion of the aorta (REBOA) for end-stage shock. The objective of this report was to describe implementation of REBOA in civilian trauma centers. Descriptive case series of REBOA (December 2012 to March 2013) used in scenarios of end-stage hemorrhagic shock at the University of Maryland, R. Adams Cowley Shock Trauma Center, Baltimore, Maryland, and Herman Memorial Hospital, The Texas Trauma Institute, Houston, Texas. REBOA was performed by trauma and acute care surgeons for blunt (n = 4) and penetrating (n = 2) mechanisms. Three cases were REBOA in the descending thoracic aorta (Zone I) and three in the infrarenal aorta (Zone III). Mean (SD) systolic blood pressure at the time of REBOA was 59 (27) mm Hg, and mean (SD) base deficit was 13 (5). Arterial access was accomplished using both direct cutdown (n = 3) and percutaneous (n = 3) access to the common femoral artery. REBOA resulted in a mean (SD) increase in blood pressure of 55 (20) mm Hg, and the mean (SD) aortic occlusion time was 18 (34) minutes. There were no REBOA-related complications, and there was no hemorrhage-related mortality. REBOA is a feasible and effective means of proactive aortic control for patients in end-stage shock from blunt and penetrating mechanisms. With available technology, this method of resuscitation can be performed by trauma and acute care surgeons who have benefited from instruction on a limited endovascular skill set. Future work should be aimed at devices that allow easy, fluoroscopy-free access and studies to define patients most likely to benefit from this procedure. Therapeutic study, level V.

1 July 2006
Verified
Journal Article
Closed access
TRTodd E. Rasmussen
Todd E. Rasmussen
WCW Darrin Clouse
W Darrin Clouse
DJDonald H. Jenkins
Donald H. Jenkins
MPMichael A. Peck
Michael A. Peck
JEJonathan L. Eliason
Jonathan L. Eliason
DSDavid L. Smith
David L. Smith
While the use of vascular shunts as a damage control adjunct has been described in series from civilian institutions no contemporary military experience has been reported. The objective of this study is to examine patterns of use and effectiveness of temporary vascular shunts in the contemporary management of wartime vascular injury. From September 1, 2004 to August 31, 2005, 2,473 combat injuries were treated at the central echelon III surgical facility in Iraq. Vascular injuries were entered into a registry and reviewed. Location of shunts was divided into proximal and distal, and shunt patency, complications and limb viability were examined. There were 126 extremity vascular injuries treated. Fifty-three (42%) had been operated on at forward locations and 30 of 53 (57%) had temporary shunts in place upon arrival to our facility. The patency for shunts in proximal vascular injuries was 86% (n = 22) compared with 12% (n = 8) for distal shunts (p < 0.05). All shunts placed in proximal venous injuries were patent (n = 4). Systemic heparin was not used and there were no shunt complications. All shunted injuries were reconstructed with vein in theater and early viability for extremities in which shunts were used was 92%. Temporary vascular shunts are common in the management of wartime vascular injury. Shunts in proximal injuries including veins have high patency rates compared with those placed in distal injuries. This vascular adjunct represents a safe and effective damage control technique and is preferable to attempted reconstruction in austere conditions.

1 December 2011 in Journal of Trauma: Injury, Infection & Critical Care
Verified
Journal Article
Closed access
ASAdam Stannard
Adam Stannard
JEJonathan L. Eliason
Jonathan L. Eliason
TRTodd E. Rasmussen
Todd E. Rasmussen